Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00833248
What this trial is testing

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 246
Testing effectiveness (Phase 2)Study completedNCT02397408
What this trial is testing

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 18
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Not applicableStudy completedNCT00688532
What this trial is testing

Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not

Who this might be right for
Prostate Cancer
AstraZeneca 5,103
Large-scale testing (Phase 3)Ended earlyNCT03921996
What this trial is testing

Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 57
Not applicableActive Not RecruitingNCT01617161
What this trial is testing

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 454
Not applicableStudy completedNCT00977860
What this trial is testing

Hypofractionated SBRT For Prostate Cancer

Who this might be right for
Prostate Cancer
Adam Olson 163
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Not applicableActive Not RecruitingNCT01936883
What this trial is testing

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 195
Not applicableNot Yet RecruitingNCT07737457
What this trial is testing

MICRO-ultrasound Guided Prostate SBRT

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 112
Not applicableStudy completedNCT00643994
What this trial is testing

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Who this might be right for
Prostate CancerProstatic CancerProstate Neoplasms+2 more
Accuray Incorporated 379
Testing effectiveness (Phase 2)UnknownNCT02165020
What this trial is testing

Hyaluronic Acid for Hypofractionated Prostate Radiotherapy

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 36
Not applicableUnknownNCT06624813
What this trial is testing

Partial Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 50
Testing effectiveness (Phase 2)Ended earlyNCT04264208
What this trial is testing

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Who this might be right for
Prostate Cancer
Andrei Iagaru 4
Not applicableStudy completedNCT03873090
What this trial is testing

SBRT in 4 Fractions for Prostate Cancer

Who this might be right for
Prostate Cancer
Istituto Clinico Humanitas 33
Not applicableStudy completedNCT01226576
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study

Who this might be right for
Localized Low-Intermediate Risk Prostate Cancer
InSightec 8
Not applicableStudy completedNCT00084552
What this trial is testing

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate CancerSexual DysfunctionSexuality and Reproductive Issues
Fox Chase Cancer Center 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT05169970
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 222
Not applicableLooking for participantsNCT06117059
What this trial is testing

The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

Who this might be right for
Localized Prostate CancerLow Risk Prostate CancerIntermediate Risk Prostate Cancer
NHS Lothian 100
Next Page